What is Rx Redefined?
Founded in 2018, Rx Redefined is revolutionizing the distribution of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). The company's platform empowers physicians to directly manage and distribute essential medical supplies to their patients, facilitating independent care management. This direct-to-physician model streamlines the supply chain and enhances patient access to necessary equipment.
How much funding has Rx Redefined raised?
Rx Redefined has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2023): $8M with participation from Crosscut Ventures Management and Silverton Partners
Key Investors in Rx Redefined
Crosscut Ventures Management
Crosscut Ventures Management is a venture capital firm operating within the private equity sector, likely focusing on companies with scalable business models and significant market potential.
Silverton Partners
Silverton Partners is an early-stage venture capital firm based in Austin, Texas, known for investing in technology-driven companies and supporting entrepreneurs with a long-term vision.
What's next for Rx Redefined?
The recent major enterprise-level funding and strategic investment signal a pivotal growth phase for Rx Redefined. This capital is expected to fuel further platform development, expand operational reach, and enhance market penetration within the healthcare technology sector. The company is strategically positioned to capitalize on the increasing demand for efficient and patient-centric medical supply solutions, aiming to solidify its leadership in direct physician-led distribution.
See full Rx Redefined company page
